PoNS Therapy

Helius Medical Technologies, Inc. is a neurotechnology company based in Newtown, Pennsylvania. Founded in 2014, the company focuses on developing non-implantable medical technologies to address symptoms caused by neurological diseases or trauma. Their flagship product, the Portable Neuromodulation Stimulator (PoNS®), is a portable device that delivers neurostimulation through the tongue. It is designed to treat gait deficits associated with multiple sclerosis, balance issues from mild-to-moderate traumatic brain injury, and gait deficits resulting from stroke symptoms, in conjunction with therapeutic exercise. Helius Medical has achieved significant regulatory milestones, including authorization for PoNS Therapy in Canada and the United States, as well as FDA Breakthrough Device Designation. The company aims to help individuals with functional neurological deficits regain independence and enhance their quality of life through innovative neurostimulation technologies. Helius Medical also offers online training for rehabilitation specialists to ensure effective use of their PoNS Therapy. With a dedicated team and substantial funding, Helius Medical Technologies is committed to advancing neurostimulation therapies for improved patient outcomes.

• Employees 21
• Annual Revenue $520000
• Total Funding $31020664